Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.

Xavier CahuMartin CarreChristian RecherArnaud PigneuxMathilde Hunault-BergerNorbert VeyPatrice ChevallierJacques DelaunayEmmanuel GyanBruno LioureCaroline BonmatiChantal HimberlinYosr HicheriGaelle GuillermBouscary DidierFabrice LarosaMario Ojeda-UribeMarc BernardMarie C BeneNorbert IfrahJean-Yves Cahn

Published in: European journal of haematology (2017)

The presence of a very high BSA is the main reason prompting physicians to reduce chemotherapy doses in adult AML. Furthermore, these patients display a poor outcome and could benefit from full doses calculated on actual BSA.

Keyphrases

acute myeloid leukemia
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
radiation therapy
young adults
allogeneic hematopoietic stem cell transplantation
locally advanced